Deficient deletion of apoptotic cells by macrophage migration inhibitory factor (MIF) overexpression accelerates photocarcinogenesis

Carcinogenesis

Volumn 30, Issue 9, 2009, Pages 1597-1605

  Honda, Ayumi ^a,b   Abe, Riichiro ^b   Yoshihisa, Yoko ^a   Makino, Teruhiko ^a   Matsunaga, Kenji ^a   Nishihira, Jun ^c   Shimizu, Hiroshi ^b   Shimizu, Tadamichi ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO INFORMATION UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; BAX PROTEIN, MOUSE; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEIN BAX; PROTEIN P53;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EPIDERMIS; GENE ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; INCIDENCE; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CANCER; TUMOR VOLUME; ULTRAVIOLET B RADIATION; WILD TYPE; ANIMAL; C57BL MOUSE; DNA DAMAGE; IMMUNOHISTOCHEMISTRY; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; NICK END LABELING; PHYSIOLOGY; RADIATION INJURY; SKIN TUMOR; TRANSGENIC MOUSE; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA DAMAGE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; NEOPLASMS, RADIATION-INDUCED; SKIN NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 70249126874     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp160     Document Type: Article

References (47)

1. Young,A.R. (1990) Cumulative effects of ultraviolet radiation on the skin: Cancer and photoaging. Semin. Dermatol., 9, 25-31.
2. Kraemer,K.H. (1997) Sunlight and skin cancer: Another link revealed. Proc. Natl Acad. Sci. USA, 94, 11-14.
3. Fischer,S.M. et al. (1999) Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol. Carcinog., 25, 231-240.
4. Pentland,A.P. et al. (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis, 20 1939-1944.
5. Cleaver,J.E. et al. (2002) UV damage, DNA repair and skin carcinogenesis. Front Biosci., 7, d1024-d1043.
6. Stenback,F. et al. (1998) p53 expression in skin carcinogenesis and its relationship to cell proliferation and tumour growth. Eur. J. Cancer, 34, 1415-1424.
7. Ansel,J.C. et al. (1988) The expression and modulation of IL-1 alpha in murine keratinocytes. J. Immunol., 140, 2274-2278.
8. Kupper,T.S. et al. (1987) Interleukin 1 gene expression in cultured human keratinocytes is augmented by ultraviolet irradiation. J. Clin. Invest., 80, 430-436.
9. Kirnbauer,R. et al. (1991) Regulation of epidermal cell interleukin-6 production by UV light and corticosteroids. J. Invest. Dermatol., 96, 484-489.
10. Kock,A. et al. (1990) Human keratinocytes are a source for tumor necrosis factor alpha: Evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med., 172, 1609-1614.
11. Suganuma,M. et al. (2002) Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation. Int. J. Oncol. 20, 131-136.
12. Bloom,B.R. et al. (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science, 153, 80-82.
13. David,J.R. (1966) Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl Acad. Sci. USA, 56, 72-77.
14. Bernhagen,J. et al. (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature, 365, 756-759.
15. Calandra,T. et al. (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med., 179, 1895-1902.
16. Lanahan,A. et al. (1992) Growth factor-induced delayed early response genes. Mol. Cell Biol., 12, 3919-3929.
17. Wistow,G.J. et al. (1993) A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc. Natl Acad. Sci. USA, 90, 1272-1275.
18. Bucala,R. (1996) MIF re-discovered: Pituitary hormone and glucocorticoid-induced regulator of cytokine production. Cytokine Growth Factor Rev., 7, 19-24.
19. Bacher,M. et al. (1997) Migration inhibitory factor expression in experimentally induced endotoxemia. Am. J. Pathol., 150, 235-246.
20. Nishihira,J. (2000) Macrophage migration inhibitory factor (MIF): Its essential role in the immune system and cell growth. J. Interferon Cytokine Res., 20, 751-762.
21. Shimizu,T. et al. (1999) High expression of macrophage migration inhibitory factor in human melanoma cells and its role in tumor cell growth and angiogenesis. Biochem. Biophys. Res. Commun., 264 751-758.
22. Chesney,J. et al. (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med., 5, 181-191.
23. Hudson,J.D. et al. (1999) A proinflammatory cytokine inhibits p53 tumor suppressor activity. J. Exp. Med., 190, 1375-1382.
24. Nemajerova,A. et al. (2007) Impaired DNA damage checkpoint response in MIF-deficient mice. EMBO J., 26, 987-997.
25. Shimizu,T. et al. (1999) Ultraviolet B radiation upregulates the production of macrophage migration inhibitory factor (MIF) in human epidermal keratinocytes. J. Invest. Dermatol., 112, 210-215.
26. Watanabe,H. et al. (2004) Ultraviolet A-induced production of matrix metalloproteinase-1 is mediated by macrophage migration inhibitory factor (MIF) in human dermal fibroblasts. J. Biol. Chem. 279, 1676-1683.
27. Shimizu,T. et al. (1997) Macrophage migration inhibitory factor is an essential immunoregulatory cytokine in atopic dermatitis. Biochem. Biophys. Res. Commun., 240, 173-178.
28. Sasaki,S. et al. (2004) Transgene of MIF induces podocyte injury and progressive mesangial sclerosis in the mouse kidney. Kidney Int. 65, 469-481.
29. Akagi,Y. et al. (1997) Transcriptional activation of a hybrid promoter composed of cytomegalovirus enhancer and beta-actin/beta-globin gene in glomerular epithelial cells in vivo. Kidney Int., 51 1265-1269.
30. Noonan,F.P. et al. (2000) Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice. Cancer Res., 60, 3738-3743.
31. Arad,S. et al. (2008) Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice. Am. J. Pathol., 172, 1248-1255.
32. Levine,A.J. (1997) p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331.
33. Kitaichi,N. et al. (2008) Macrophage migration inhibitory factor ameliorates UV-induced photokeratitis in mice. Exp. Eye Res., 86, 929-935.
34. Fingerle-Rowson,G. et al. (2003) The p53-dependent effects of macrophage migration inhibitory factor revealed by gene targeting. Proc. Natl Acad. Sci. USA, 100, 9354-9359.
35. Martin,J. et al. (2008) Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC). FASEB J., 23, 720-730.
36. Moore,R.J. et al. (1999) Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. Nat. Med., 5 828-831.
37. Wilgus,T.A. et al. (2003) Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol. Carcinog., 38, 49-58.
38. Bach,J.P. et al. (2008) Role of MIF in inflammation and tumorigenesis. Oncology, 75, 127-133.
39. Meyer-Siegler,K. et al. (1998) Expression of macrophage migration inhibitory factor in the human prostate. Diagn. Mol. Pathol., 7 44-50.
40. Legendre,H. et al. (2003) Prognostic values of galectin-3 and the macrophage migration inhibitory factor (MIF) in human colorectal cancers. Mod. Pathol., 16, 491-504.
41. Ren,Y. et al. (2003) Macrophage migration inhibitory factor: Roles in regulating tumor cell migration and expression of angiogenic factors in hepatocellular carcinoma. Int. J. Cancer, 107, 22-29.
42. Kamimura,A. et al. (2000) Intracellular distribution of macrophage migration inhibitory factor predicts the prognosis of patients with adenocarcinoma of the lung. Cancer, 89, 334-341.
43. Rogge,L. (2002) A genomic view of helper T cell subsets. Ann. N. Y. Acad. Sci., 975, 57-67.
44. Takahashi,N. et al. (1998) Involvement of macrophage migration inhibitory factor (MIF) in the mechanism of tumor cell growth. Mol. Med., 4, 707-714.
45. Meyer-Siegler,K.L. et al. (2006) Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J. Immunol., 177, 8730-8739.
46. Abe,R. et al. (2001) Regulation of the CTL response by macrophage migration inhibitory factor. J. Immunol., 166, 747-753.
47. Hagemann,T. et al. (2007) Ovarian cancer cell-derived migration inhibitory factor enhances tumor growth, progression, and angiogenesis. Mol. Cancer Ther., 6, 1993-2002.